NCT03595891 The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung Status COMPLETED Phase N/A
NCT03594045 Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT) Status TERMINATED Phase PHASE2
NCT03590210 Combined Treatment With Nivolumab and Trabectedin in Patients With Metastatic or Inoperable Soft Tissue Sarcomas Status COMPLETED Phase PHASE2
NCT03586999 Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas Status COMPLETED Phase PHASE1/PHASE2
NCT03585465 Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT03583086 Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT03583008 Supporting Use of AC Through Provider Profiling of Oral AC Therapy for AF Status COMPLETED Phase NA
NCT03576963 Guadecitabine and Nivolumab in Treating Refractory Metastatic Colorectal Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT03576612 GMCI, Nivolumab, and Radiation Therapy in Treating Patients With Newly Diagnosed High-Grade Gliomas Status COMPLETED Phase PHASE1
NCT03575793 A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT03575234 Nivolumab & IRX-2 With Surgery for Resectable Stage III-IVA Oral Cavity Cancer or HPV-Positive Oropharyngeal Cancer Status WITHDRAWN Phase PHASE1
NCT03572582 Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma Status COMPLETED Phase PHASE2
NCT03572478 Rucaparib and Nivolumab in Patients With Prostate or Endometrial Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT03569436 Effectiveness and Safety of Nivolumab in Participants That Have Head and Neck Cancer That Has Come Back or Has Spread Status COMPLETED Phase N/A
NCT03568435 Safety and Effectiveness of Nivolumab in Recurring Kidney Cancer Participants Status COMPLETED Phase N/A
NCT03566264 Study of the Sudden Heart Failure Participant Population in the US Status WITHDRAWN Phase N/A
NCT03563950 An Investigational Study to Evaluate the Effect of Rifampin on the Singe Dose of Experimental Medication BMS-986224 in Healthy Participants Status COMPLETED Phase PHASE1
NCT03563248 Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2